Caribou Biosciences to Participate in the Jefferies Global Healthcare Conference
Caribou Biosciences (NASDAQ: CRBU), a clinical-stage CRISPR genome-editing biopharmaceutical company, announced that its President and CEO, Rachel Haurwitz, PhD, will participate in a fireside chat at the Jefferies Global Healthcare Conference. The presentation is scheduled for June 4th at 9:20 AM EDT. The webcast will be accessible through Caribou's website and will remain available for at least 30 days following the event.
Caribou Biosciences (NASDAQ: CRBU), una società biofarmaceutica in fase clinica specializzata nell'editing genomico CRISPR, ha annunciato che la sua Presidente e CEO, Rachel Haurwitz, PhD, parteciperà a una conversazione informale durante la Jefferies Global Healthcare Conference. La presentazione è prevista per il 4 giugno alle 9:20 AM EDT. Il webcast sarà disponibile sul sito web di Caribou e resterà accessibile per almeno 30 giorni dopo l'evento.
Caribou Biosciences (NASDAQ: CRBU), una compañía biofarmacéutica en etapa clínica especializada en edición genómica CRISPR, anunció que su Presidenta y CEO, Rachel Haurwitz, PhD, participará en una charla informal en la Jefferies Global Healthcare Conference. La presentación está programada para el 4 de junio a las 9:20 AM EDT. La transmisión por internet estará disponible en el sitio web de Caribou y permanecerá accesible durante al menos 30 días después del evento.
Caribou Biosciences (NASDAQ: CRBU)는 임상 단계의 CRISPR 유전체 편집 생명공학 제약회사로, 사장 겸 CEO인 Rachel Haurwitz, PhD가 Jefferies Global Healthcare Conference에서 화상 대화에 참여할 예정임을 발표했습니다. 발표는 6월 4일 오전 9시 20분 EDT에 예정되어 있습니다. 웹캐스트는 Caribou 웹사이트를 통해 시청할 수 있으며, 행사 후 최소 30일간 이용 가능합니다.
Caribou Biosciences (NASDAQ : CRBU), une société biopharmaceutique en phase clinique spécialisée dans l'édition génomique CRISPR, a annoncé que sa Présidente et CEO, Rachel Haurwitz, PhD, participera à une discussion informelle lors de la Jefferies Global Healthcare Conference. La présentation est prévue pour le 4 juin à 9h20 EDT. Le webdiffusion sera accessible via le site web de Caribou et restera disponible pendant au moins 30 jours après l'événement.
Caribou Biosciences (NASDAQ: CRBU), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf CRISPR-Genom-Editing spezialisiert hat, gab bekannt, dass seine Präsidentin und CEO, Rachel Haurwitz, PhD, an einem Gespräch beim Jefferies Global Healthcare Conference teilnehmen wird. Die Präsentation ist für den 4. Juni um 9:20 Uhr EDT geplant. Das Webcast wird über die Website von Caribou zugänglich sein und mindestens 30 Tage nach der Veranstaltung verfügbar bleiben.
- None.
- None.
BERKELEY, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, today announced Rachel Haurwitz, PhD, Caribou’s president and chief executive officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on June 4th at 9:20 AM EDT.
For more information and a link to the webcast, visit the Events page on Caribou’s website. Webcasts will be available on the Caribou website for at least 30 days after the event.
About Caribou Biosciences, Inc.
Caribou Biosciences is a clinical-stage CRISPR genome-editing biopharmaceutical company dedicated to developing transformative therapies for patients with devastating diseases. The company’s genome-editing platform, including its Cas12a chRDNA technology, enables superior precision to develop cell therapies that are armored to potentially improve activity against diseases. Caribou is focused on CB-010 and CB-011 as off-the-shelf CAR-T cell therapies that have the potential to provide broad access and rapid treatment for patients with hematologic malignancies. Follow us @CaribouBio and visit www.cariboubio.com.
Caribou Biosciences, Inc. contacts:
Investors:
Amy Figueroa, CFA
investor.relations@cariboubio.com
Media:
Peggy Vorwald, PhD
media@cariboubio.com
FAQ
When is Caribou Biosciences (CRBU) presenting at the Jefferies Global Healthcare Conference?
Who will represent Caribou Biosciences (CRBU) at the Jefferies Healthcare Conference?
How long will the Caribou Biosciences (CRBU) Jefferies Conference webcast be available?
What type of company is Caribou Biosciences (CRBU)?
